Dynavax Technologies Corporation (DVAX): Price and Financial Metrics

DVAX POWR Grades

• DVAX scores best on the Value dimension, with a Value rank ahead of 90.35% of US stocks.
• DVAX's strongest trending metric is Quality; it's been moving up over the last 177 days.
• DVAX's current lowest rank is in the Growth metric (where it is better than 0.25% of US stocks).

DVAX Stock Summary

• With a price/sales ratio of 3.82, DYNAVAX TECHNOLOGIES CORP has a higher such ratio than 74.23% of stocks in our set.
• In terms of twelve month growth in earnings before interest and taxes, DYNAVAX TECHNOLOGIES CORP is reporting a growth rate of -50.52%; that's higher than 25.38% of US stocks.
• As for revenue growth, note that DVAX's revenue has grown -31.82% over the past 12 months; that beats the revenue growth of merely 8.23% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to DYNAVAX TECHNOLOGIES CORP, a group of peers worth examining would be BL, PWSC, DOCS, CHGG, and SWAV.
• DVAX's SEC filings can be seen here. And to visit DYNAVAX TECHNOLOGIES CORP's official web site, go to www.dynavax.com.

DVAX Valuation Summary

• In comparison to the median Healthcare stock, DVAX's price/sales ratio is 100% higher, now standing at 3.8.
• Over the past 238 months, DVAX's price/sales ratio has gone down 265.6.

Below are key valuation metrics over time for DVAX.

DVAX Growth Metrics

Its 4 year net cashflow from operations growth rate is now at -2.9%.
• Its year over year cash and equivalents growth rate is now at 126.58%.
• Its 4 year net income to common stockholders growth rate is now at -16.33%.

DVAX's revenue has moved up $698,042,000 over the prior 33 months.

The table below shows DVAX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	733.261	148.265	320.633
2022-06-30	673.796	152.916	228.394
2022-03-31	470.099	247.053	104.112
2021-12-31	439.442	335.528	72.144
2021-09-30	263.922	199.288	-38.533
2021-06-30	169.066	105.256	-5.702

DVAX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• DVAX has a Quality Grade of B, ranking ahead of 88.86% of graded US stocks.
• DVAX's asset turnover comes in at 0.367 -- ranking 129th of 681 Pharmaceutical Products stocks.
• LJPC, ABT, and CVM are the stocks whose asset turnover ratios are most correlated with DVAX.

The table below shows DVAX's key quality metrics over time.